Skip to content
Screener

DiaMedica Therapeutics DMAC Q2 2026 earnings

Reported August 10, 2026 · After market close

EPS-$0.19Beat by $0.01
Revenue estimate$13.5M
EPS estimate-$0.20

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$13.5M
EPS estimate-$0.20

FAQ

When did DiaMedica Therapeutics report Q2 2026 earnings?
DiaMedica Therapeutics (DMAC) reported Q2 2026 earnings on August 10, 2026 after market close.
What were DiaMedica Therapeutics's Q2 2026 revenue and EPS?
DiaMedica Therapeutics reported eps of $-0.19 for Q2 2026.
Did DiaMedica Therapeutics beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.20 by $0.01.
How did DiaMedica Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 5.6% from $-0.18.
Where can I find DiaMedica Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-026790) and the 10-Q periodic report (0001437749-26-026792) directly on SEC EDGAR. The filing index links above go to sec.gov.